Where do Climb Bio, Inc.'s ratios come from?

Every ratio is computed from Climb Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Climb Bio, Inc. CLYM Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-30.9%+31.1pp	-32.1%+14.1pp	-25.6%+16.4pp	-22.9%+15.4pp	-62%-49.0pp
Return on assets	-29.9%+30.1pp	-31.1%+14.0pp	-25.1%+16.2pp	-22.4%+15.2pp	-60%-47.4pp
Return on invested capital	-39.4%+83.2pp	-54.2%+63.0pp	-53%+68.5pp	——	-122.6%-75.8pp
Liquidity
Current ratio	27.9×+13.6×	15.2×-16.3×	18.4×-39.4×	14.1×-46.3×	14.3×-22.8×
Quick ratio	27.9×+13.6×	15.2×-16.3×	18.4×-39.4×	14.1×-46.3×	14.3×-22.8×
Cash ratio	2.1×-2.1×	5.1×-12.6×	5.2×-37.5×	3.7×-56.0×	4.1×-31.5×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$2.17-24.3%	$2.37-46.2%	$2.60-20.3%	$2.75-62.5%	$2.87-25.5%
Valuation
Market capitalization	$724.95M+787%	$190.98M+57.8%	$136.21M—	$87.17M—	$82.32M—
Enterprise value	$717.07M+1,247%	$155.83M+354%	$110.98M—	$65.13M—	$53.77M—
Price / book	4.9×+4.5×	1.2×+0.6×	0.8×—	0.5×—	0.4×—
Earnings yield	-7.3%+106pp	-31.3%+29.7pp	-37.3%—	-53.6%—	-113%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Climb Bio, Inc.'s ratios come from?: Every ratio is computed from Climb Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.